应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CV CapsoVision, Inc.
休市中 10-02 16:00:00 EDT
6.17
-0.15
-2.37%
盘后
6.17
+0.00
0.00%
19:30 EDT
最高
6.40
最低
6.12
成交量
12.87万
今开
6.35
昨收
6.32
日振幅
4.43%
总市值
3.28亿
流通市值
2.14亿
总股本
5,321万
成交额
79.92万
换手率
0.37%
流通股本
3,466万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
CapsoVision推进IPO:拟发行320万股,定价每股5.69美元,预计募资约1800万美元
美股速递 · 09-19
CapsoVision推进IPO:拟发行320万股,定价每股5.69美元,预计募资约1800万美元
Capsovision拟通过SEC文件发行高达2.5亿美元证券,涵盖普通股、优先股、认股权证等多种工具
美股速递 · 08-14
Capsovision拟通过SEC文件发行高达2.5亿美元证券,涵盖普通股、优先股、认股权证等多种工具
CapsoVision与Cantor Fitzgerald签署最高1亿美元ATM发行销售协议
美股速递 · 08-14
CapsoVision与Cantor Fitzgerald签署最高1亿美元ATM发行销售协议
新闻稿:CapsoVision任命胃肠病学专家David S. Shields医学博士加入董事会
投资观察 · 07-03
新闻稿:CapsoVision任命胃肠病学专家David S. Shields医学博士加入董事会
计算机视觉市场迈入CV 2.0,行业正从“看”迈向“看懂、会搜、能生成”
上观新闻 · 05-20
计算机视觉市场迈入CV 2.0,行业正从“看”迈向“看懂、会搜、能生成”
加载更多
公司概况
公司名称:
CapsoVision, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
CapsoVision, Inc.于2005年8月1日根据特拉华州法律注册成立,名称为“Capso Vision, Inc.”,并于2016年5月31日更名为CapsoVision, Inc.。该公司是一家商业阶段的医疗技术公司,开发先进的成像和人工智能技术,这些技术部署在他们的胶囊内窥镜解决方案中,用于识别胃肠道异常,用于诊断和筛查目的。
发行价格:
--
{"stockData":{"symbol":"CV","market":"US","secType":"STK","nameCN":"CapsoVision, Inc.","latestPrice":6.17,"timestamp":1790971200000,"preClose":6.32,"halted":0,"volume":128724,"hourTrading":{"tag":"盘后","latestPrice":6.17,"preClose":6.17,"latestTime":"19:30 EDT","volume":1796,"amount":11081.32,"timestamp":1790983804910,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.023734177215189927,"floatShares":34660900,"shares":53210400,"eps":-0.624106,"marketStatus":"休市中","change":-0.15,"latestTime":"10-02 16:00:00 EDT","open":6.35,"high":6.4,"low":6.12,"amount":799152.1889640001,"amplitude":0.044304,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.624106,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1751428800000,"exchange":"NASDAQ","adjPreClose":6.32,"postHourTrading":{"tag":"盘后","latestPrice":6.17,"preClose":6.17,"latestTime":"19:30 EDT","volume":1796,"amount":11081.32,"timestamp":1790983804910,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5865808761595018},"requestUrl":"/m/hq/s/CV","defaultTab":"news","newsList":[{"id":"1141416513","title":"CapsoVision推进IPO:拟发行320万股,定价每股5.69美元,预计募资约1800万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141416513","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141416513?lang=zh_cn&edition=full","pubTime":"2026-09-19 02:37","pubTimestamp":1789756630,"startTime":"0","endTime":"0","summary":"CapsoVision正加速其上市进程。根据美国证券交易委员会的最新文件披露,该公司计划公开发行320万股股票,发行价锁定在每股5.69美元。这一举措预计将为公司带来约1800万美元的总收益。此次发行规模与定价策略,反映出CapsoVision在当前市场环境下的融资考量。文件细节显示,此次股票发行已进入实质性推进阶段。CapsoVision此次IPO若顺利完成,将为其在医疗器械或相关领域的竞争格局中增添新的筹码。投资者正密切关注其后续定价调整及上市首日的市场表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166892695","title":"Capsovision拟通过SEC文件发行高达2.5亿美元证券,涵盖普通股、优先股、认股权证等多种工具","url":"https://stock-news.laohu8.com/highlight/detail?id=1166892695","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166892695?lang=zh_cn&edition=full","pubTime":"2026-08-14 04:49","pubTimestamp":1786654152,"startTime":"0","endTime":"0","summary":"Capsovision, Inc. 近日向美国证券交易委员会(SEC)提交了重磅文件。根据文件内容,这家公司可能计划筹集巨额资金。具体来看,发行总额最高可达2.5亿美元。这一数字不容小觑,彰显了公司的资本运作雄心。发行的证券品种极为丰富,并非单一选择。其中包括普通股,这是基础权益工具。还有优先股,能为投资者带来优先分红等权利。此外,公司还可能发行认股权证,赋予持有者在特定条件下购买股票的权利。同时,权利(Rights)和单位(Units)也在发行计划之列。这种多元化的结构设计,无疑为潜在投资者提供了灵活多样的选择。整个发行方案显现出公司对资本市场的深度布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164791264","title":"CapsoVision与Cantor Fitzgerald签署最高1亿美元ATM发行销售协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1164791264","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164791264?lang=zh_cn&edition=full","pubTime":"2026-08-14 04:14","pubTimestamp":1786652049,"startTime":"0","endTime":"0","summary":"CapsoVision, Inc. 已与 Cantor Fitzgerald 达成一项销售协议,涉及一项最高可达1亿美元的“按市价发售”(At-the-Market Offering)计划。该消息源自美国证券交易委员会(SEC)的相关文件披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CV","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174465901","title":"新闻稿:CapsoVision任命胃肠病学专家David S. Shields医学博士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1174465901","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174465901?lang=zh_cn&edition=full","pubTime":"2026-07-03 04:08","pubTimestamp":1783022915,"startTime":"0","endTime":"0","summary":"加利福尼亚州萨拉托加,2026年7月2日——处于商业化阶段的医疗技术公司CapsoVision, Inc.宣布,任命David S. Shields医学博士为公司董事会成员,该任命自2026年7月1日起生效。近十年来,他一直担任CapsoVision的临床顾问和咨询专家。此次任命后,他将接替Joanne C. Imperial医学博士的董事席位。Imperial博士已从董事会卸任,并将继续以独立临床顾问的身份为公司提供支持。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4555","BK4588","R","03160","BK4232","BK4585","BK4604","TM","BK4022","CV","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636810140","title":"计算机视觉市场迈入CV 2.0,行业正从“看”迈向“看懂、会搜、能生成”","url":"https://stock-news.laohu8.com/highlight/detail?id=2636810140","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636810140?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:12","pubTimestamp":1779268370,"startTime":"0","endTime":"0","summary":"近日,国际数据公司(IDC)发布《中国AI软件市场》报告:2025年中国视觉AI市场,商汤科技再度登顶行业榜首,实现“十连冠”。IDC在报告中指出,计算机视觉市场正经历从“CV1.0”到“CV2.0”的深刻变革。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605203743564683.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743564683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159998","BK4082","CV"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://capsovision.com","stockEarnings":[{"period":"1week","weight":-0.0722},{"period":"1month","weight":0.0405},{"period":"3month","weight":-0.1525},{"period":"6month","weight":-0.1707},{"period":"1year","weight":0.2854},{"period":"ytd","weight":-0.4228}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CapsoVision, Inc.于2005年8月1日根据特拉华州法律注册成立,名称为“Capso Vision, Inc.”,并于2016年5月31日更名为CapsoVision, Inc.。该公司是一家商业阶段的医疗技术公司,开发先进的成像和人工智能技术,这些技术部署在他们的胶囊内窥镜解决方案中,用于识别胃肠道异常,用于诊断和筛查目的。","exchange":"NASDAQ","name":"CapsoVision, Inc.","nameEN":"CapsoVision, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CapsoVision, Inc.(CV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CapsoVision, Inc.(CV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CapsoVision, Inc.,CV,CapsoVision, Inc.股票,CapsoVision, Inc.股票老虎,CapsoVision, Inc.股票老虎国际,CapsoVision, Inc.行情,CapsoVision, Inc.股票行情,CapsoVision, Inc.股价,CapsoVision, Inc.股市,CapsoVision, Inc.股票价格,CapsoVision, Inc.股票交易,CapsoVision, Inc.股票购买,CapsoVision, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CapsoVision, Inc.(CV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CapsoVision, Inc.(CV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}